An estimated 40% (95% CI, 35%–45%) of BRCA1 carriers and 26% (95% CI, 20%–33%) of BRCA2 carriers develop contralateral breast cancer within 20 years following an initial breast cancer diagnosis.10 The gene discussed is BRCA2; the disease is breast cancer.